Abstract 218: R-Spondin (RSPO) signaling drives the growth of multiple human tumor types.
Austin Gurney(Australian Centre for Heart Health), Timothy Hoey, John Lewicki(OncoMed (United States)), Wan-Ching Yen(OncoMed (United States)), Christopher Bond(Heart of England NHS Foundation Trust), Marcus Fischer(St. Jude Children's Research Hospital), Janak Raval(OncoMed (United States)), May Ji(OncoMed (United States)), Fumiko Axelrod(OncoMed (United States)), Christopher L. Murriel, Ann M. Kapoun(OncoMed (United States)), Jalpa Shah(OncoMed (United States)), Jennifer Cain(Gilead Sciences (United States)), Cécile Chartier(Io Therapeutics (United States))
Cited by 0
Related Papers
Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli
|Journal of Virology|1996|651
Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
|Proceedings of the National Academy of Sciences|2012|630
Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy
|PLoS ONE|2008|582
Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma
|Journal of Clinical Oncology|2021|431
IL-17E, a Novel Proinflammatory Ligand for the IL-17 Receptor Homolog IL-17Rh1
|Journal of Biological Chemistry|2001|410